Pharmaceuticals significantly impact the health of American families. When weaknesses are exposed in the pharmaceutical supply chain, it presents an opportunity for potentially dangerous counterfeit drugs to enter the U.S. market.

In the article, "Protect Patients by Strengthening Supply Chain" in Roll Call, Vince Ventimiglia explained that all stakeholders in the pharmaceutical supply chain have rallied around a single proposed solution to give the Food and Drug Administration (FDA) the authority needed to protect the integrity of U.S. pharmaceuticals. In the article, he described the supported legislative solution, the authority that would be extended to FDA and the anticipated impacts.